Volume 6, Number 3, Jul-Aug-Sep 2009

Making sense of HDL cholesterol in cardiovascular risk
Dr Jonathan Morrell

Lowering LDL cholesterol (LDL-C) with statins for the prevention of cardiovascular disease (CVD) has rightly become a core activity for primary care health professionals. However, despite effective lowering of LDL-C, many patients still suffer cardiovascular events. Experts have called this ‘the residual risk’ and have speculated whether further cardiovascular events can be prevented by attention to other lipoprotein fractions, particularly HDL cholesterol (HDL-C).

View full PDF article (open in new window)
Email this article